• English
    • Deutsch
View Item 
  •   OPARU Home
  • Universitätsklinikum Ulm
  • Publikationsnachweise
  • View Item
  •   OPARU Home
  • Universitätsklinikum Ulm
  • Publikationsnachweise
  • View Item
  • English 
    • English
    • Deutsch
  • Login
JavaScript is disabled for your browser. Some features of this site may not work without it.

A Randomized, Double-blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease

Erstveröffentlichung
2013
Metadata only
Search for full text
Wissenschaftlicher Artikel


Authors
Kieburtz, Karl
Landwehrmeyer, Georg B.
Cudkowicz, Merit
Dorsey, E. Ray
Feigin, Andrew
et al.
Institutions
UKU. Klinik für Neurologie
Published in
JAMA neurology ; 70 (2013), 1. - S. 25-33. - ISSN 2168-6149. - eISSN 2168-6157
Link to publication
https://dx.doi.org/10.1001/2013.jamaneurol.382
Keywords
MINI-MENTAL-STATE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; CONTROLLED-TRIAL; DEMENTIA; DONEPEZIL; DIMEBON; RIVASTIGMINE; DYSFUNCTION; INVENTORY
Dewey Decimal Group
DDC 610 / Medicine & health

Metadata
Show full item record

This could also interest you:

  • Identification of symbol digit modality test score extremes in Huntington's disease 

    Braisch, Ulrike et al. (2019)
    Wissenschaftlicher Artikel

  • Pan-cancer analysis of whole genomes 

    Campbell, Peter J. et al. (2020)
    Wissenschaftlicher Artikel

  • Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 

    Vos, Theo et al. (2017)
    Wissenschaftlicher Artikel


About OPARU | Contact Us
Impressum | Privacy statement
 

 

Advanced Search

Browse

All of OPARUCommunities & CollectionsFacultiesInstitutionsPersonsResource typesUlm SerialsDewey Decimal ClassesFundingThis CollectionFacultiesInstitutionsPersonsResource typesUlm SerialsDewey Decimal ClassesFunding

My Account

LoginRegister

Statistics

View Usage Statistics

About OPARU | Contact Us
Impressum | Privacy statement